SELECT LANGUAGE BELOW

Stock Market Update, Feb. 9: Kyndryl’s Share Price Cut in Half After Earnings Shortfall and Postponed Filing

Stock Market Update, Feb. 9: Kyndryl's Share Price Cut in Half After Earnings Shortfall and Postponed Filing

On February 9, 2026, investors are dealing with a rather unusual mix of factors at the IT services giant. There’s an ongoing accounting review, a management shakeup, and now, legal issues are in the spotlight.

kindril stock price

Changes Today

(-54.92%) $-12.90

Current Price

$10.59

Key Data Points

Market Capitalization

$2.4 billion

Daily Range

$10.10 – $11.43

52 Week Range

$10.10 – $44.20

Volume

61M

Average Volume

3.2M

Gross Profit

35.77%

Kindril (K.D. 54.92%) saw its stock drop 54.94% to close at $10.59 on Monday. This significant decline followed disappointing profit and sales figures, news of an accounting review, delays in filing their 10-Q, and the resignation of a top finance executive.
Trading volume hit 59.3 million shares, an increase of approximately 1,777% compared to the three-month average of 3.2 million. Since its IPO in 2021, Kyndryl’s stock has plummeted by 74%.

Market Movements Today

The U.S. markets performed relatively well on Monday. The S&P 500 jumped by 0.45% to 6,963, while the Nasdaq Composite rose by 0.90% to 23,239. Among peers in the IT services sector, International Business Machines closed at $296.34 (-0.87%), and DXC Technology fell to $14.33 (-5.72%), indicating some pressure on traditional IT service providers.

Implications for Investors

Kyndryl’s third-quarter report delivered disappointing news. Sales and profit figures came in below Wall Street forecasts, with only a 3% increase in sales. However, the bigger concern was the announcement of a delay in their Form 10-Q due to “material weaknesses in internal controls.”

This has prompted a reorganization within the finance and legal departments, most notably resulting in the CFO’s exit. To complicate matters further, the steep stock drop has led several law firms to initiate securities fraud investigations against Kindril, adding to the challenges ahead.

Though Kyndryl might seem undervalued right now, I think it’s wise to hold off until these issues are more clearly understood.

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp
Category
© Copyright 1996 – 2022, Total News LLC | Terms |  Privacy  | Support